ALLMedicine™ Parathyroid Carcinoma Center
Research & Reviews 525 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048281
Journal of Cardiothoracic Surgery; Kawagishi S, Funaki S et. al.
Apr 16th, 2021 - A rare cause of primary hyperparathyroidism (PHPT) is a parathyroid carcinoma. Hypercalcemia with an elevated parathyroid hormone (PTH) level seen in recurrent and metastasis disease cases is often refractory to medical therapy, thus surgical rese...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043017
BMJ Case Reports; Wong G, Ghabbour A et. al.
Apr 10th, 2021 - Giant parathyroid adenomas are rare and underreported benign tumours of parathyroid gland. Preoperative differentiation between giant parathyroid adenoma (GPA) and parathyroid carcinoma can be challenging, as they both may present as a large parat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028146
BMC Endocrine Disorders; De Falco N, Santangelo G et. al.
Apr 8th, 2021 - Parathyroid carcinoma is a rare endocrine malignancy, rarer when synchronous with a non medullary well differentiated thyroid carcinoma. Parathyroid carcinoma accounts of 0.005% of all malignant tumors and it is responsible for less than 1% of pri...
https://doi.org/10.1002/hed.26677
Head & Neck; Shah R, Gosavi V et. al.
Mar 22nd, 2021 - Parathyroid carcinoma (PC) requires preoperative prediction for appropriate surgical management. Differentiation from symptomatic primary hyperparathyroidism (sPHPT) cohort is difficult. Patients with sPHPT from a tertiary-care center, Western Ind...
https://doi.org/10.1007/s00432-021-03576-9 10.1111/j.1445-2197.2010.05594.x 10.1002/hed.20049 10.1016/j.bone.2014.12.003 10.1210/jc.2011-1571 10.1002/(sici)1097-0142(19990801)86:3<538::aid-cncr25>3.0.co;2-k 10.1001/archsurg.136.8.878 10.1002/hed.21716 10.4174/astr.2018.94.5.235 10.1002/cncr.22599 10.1007/bf01665308 10.1002/bjs.5608 10.1016/j.surg.2009.10.021 10.1016/j.jss.2005.04.026 10.1080/0284186x.2017.1306103 10.1007/bf02067369 10.1007/bf00353773 10.1210/jcem.86.2.7207 10.1056/NEJMoa031237 10.1158/1078-0432.Ccr-04-0493 10.1007/s11864-011-0171-3 10.1097/00005792-199207000-00002 10.1210/jc.2012-4022 10.1055/s-0043-125334
Journal of Cancer Research and Clinical Oncology; Kong SH, Kim JH et. al.
Mar 19th, 2021 - Parathyroid carcinoma (PC) is an exceedingly rare endocrine malignancy with a poor prognosis. Due to the rarity, the natural course and prognostic factors of the disease are yet unclear. Therefore, we aimed to identify the incidence, prognosis, an...
Guidelines 1 results
https://doi.org/10.1007/s00259-009-1131-z
European Journal of Nuclear Medicine and Molecular Imaging; Hindié E, Ugur O et. al.
May 27th, 2009 - The present guidelines were issued by the Parathyroid Task Group of the European Association of Nuclear Medicine. The main focus was imaging of primary hyperparathyroidism. Dual-tracer and single-tracer parathyroid scintigraphy protocols were disc...
Drugs 49 results see all →
Clinicaltrials.gov 581 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048281
Journal of Cardiothoracic Surgery; Kawagishi S, Funaki S et. al.
Apr 16th, 2021 - A rare cause of primary hyperparathyroidism (PHPT) is a parathyroid carcinoma. Hypercalcemia with an elevated parathyroid hormone (PTH) level seen in recurrent and metastasis disease cases is often refractory to medical therapy, thus surgical rese...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043017
BMJ Case Reports; Wong G, Ghabbour A et. al.
Apr 10th, 2021 - Giant parathyroid adenomas are rare and underreported benign tumours of parathyroid gland. Preoperative differentiation between giant parathyroid adenoma (GPA) and parathyroid carcinoma can be challenging, as they both may present as a large parat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028146
BMC Endocrine Disorders; De Falco N, Santangelo G et. al.
Apr 8th, 2021 - Parathyroid carcinoma is a rare endocrine malignancy, rarer when synchronous with a non medullary well differentiated thyroid carcinoma. Parathyroid carcinoma accounts of 0.005% of all malignant tumors and it is responsible for less than 1% of pri...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4dc0bbfe-eb96-4351-a245-84f001389834
Mar 31st, 2021 - Cinacalcet tablets are a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. (1.1) Limitations of Use: Cinacalcet tablets are not ...
https://doi.org/10.1002/hed.26677
Head & Neck; Shah R, Gosavi V et. al.
Mar 22nd, 2021 - Parathyroid carcinoma (PC) requires preoperative prediction for appropriate surgical management. Differentiation from symptomatic primary hyperparathyroidism (sPHPT) cohort is difficult. Patients with sPHPT from a tertiary-care center, Western Ind...
News 2 results
https://www.medscape.com/viewarticle/468503_3
Feb 27th, 2005 - Discussion The case of this unfortunate patient presents several points of interest. Brown tumors are rare, seen in fewer than 5% of patients with primary hyperparathyroidism today. Early detection of hypercalcemia due to rapid multichannel bioche...
https://www.mdedge.com/ccjm/article/92761/parathyroid-carcinoma-50-year-experience-cleveland-clinic-foundation
Abstract BACKGROUND Parathyroid carcinoma is rare, with a reported prevalence of 0. 6% to 4.
